Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

In Vitro Drug Response Profiling in BCP- and T-ALL Primary Samples Adds a Robust Functional Layer Enabling Optimized Guidance of Individualized Therapy in Relapsed and Refractory Pediatric Acute Leukemia Patients

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-142314

Published: 2020

Journal Articles

Transient Switch to Myeloid Lineage in Acute Lymphoblastic Leukemia during Induction Therapy: The Role of CD371 Expression and Implication for Minimal Residual Disease Detection

Elena Varotto, MD PhD, Margarita Maurer-Granofszky, PhD, Daniela Silvestri, Pamela Scarparo, PhD, Ester Mejstrikova, MD PhD, Monika Brüggemann, Giovanni Cazzaniga, PhD, Valentino Conter, MD, Ondrej Hrusak, MD PhD, Giuseppe Gaipa, PhD, Angela Schumich, Maria Grazia Valsecchi, PhD, Giuseppe Basso, MD PhD, Michael Dworzak, MD, Barbara Buldini, MD PhD

Blood (2019) 134 (Supplement_1): 377.

https://doi.org/10.1182/blood-2019-127287

Published: 2019

Journal Articles

Deep Immunoprofiling By Flow Cytometry and NGS Reveals Distinct T Cell Profile in Pediatric Hepatitis-Associated Aplastic Anemia

Michaela Novakova, Michael Svaton, MD, Martina Sukova, MD, Veronika Kanderova, MSc, PhD, Nikos Darzentas, PhD, Lenka Kramna, MSc, PhD, Ondrej Cinek, Prof., MD PhD, Dagmar Pospisilova, Prof MD PhD, Jan Trka, Prof., MD PhD, Ondrej Hrusak, MD PhD, Jan Stary, Prof., MD PhD, Ester Mejstrikova, MD PhD, Eva Fronkova, MD PhD

Blood (2019) 134 (Supplement_1): 2508.

https://doi.org/10.1182/blood-2019-127986

Published: 2019

Journal Articles

Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies

Ondrej Hrusak, MD PhD, Valerie De Haas, MD PhD, Ales Luks, Iveta Janotova, Ester Mejstrikova, MD PhD, Kirsten Bleckmann, MD, Anja Moricke, MD, Julie Irving, PhD, Benigna Konatkowska, Thomas B. Alexander, MD MPH, Hiroto Inaba, MD PhD, Kjeld Schmiegelow, MD DMSc, Simone Stokley, FRCPath,, Jorge Gabriel Rossi, PhD, Maria Sara Felice, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Jessa Morales, Michael Dworzak, MD, Barbara Buldini, MD, Giuseppe Basso, Myriam Campbell, Maria Elena Cabrera, Neda Marinov, Sarah Elitzur, MD, Shai Izraeli, MD, Drorit Luria, PhD, Tamar Feuerstein, PhD, Alexandra Kolenova, MD PhD, Peter Svec, Elena Kreminska, Karen R. Rabin, MD, Sophia Polychronopoulou, MD PhD, Elaine da Costa, Hanne Vibeke Marquart, MD PhD, Antonis Kattamis, MD, Richard Ratei, Dirk Reinhardt, MD PhD, Anthony V Moorman, PhD, Martin Schrappe, MD, Jan Stary, MD D.Sc.

Blood (2016) 128 (22): 584.

https://doi.org/10.1182/blood.V128.22.584.584

Published: 2016

Journal Articles

Genomic Landscape of Pediatric Mixed Phenotype Acute Leukemia

Thomas B. Alexander, MD MPH, Zhaohui Gu, PhD, John K Choi, MD, Mignon L. Loh, MD, John Horan, MD MPH, Barbara Buldini, MD, Giuseppe Basso, Sarah Elitzur, MD, C. Michel Zwaan, MD PhD, Valerie de Haas, MD PhD, Allen Eng Juh Yeoh, MD, Dirk Reinhardt, MD PhD, Daisuke Tomizawa, MD, PhD, Tim Lammens, Barbara De Moerloose, MD, Li Zhou, PhD, Hiroki Hori, MD PhD, Anthony V. Moorman, PhD, Andrew S. Moore, MBBS FRACP PhD, Ondrej Hrusak, MD PhD, Soheil Meshinchi, MD PhD, Etan Orgel, MD MS, Meenakshi Devidas, PhD, Stephen P. Hunger, MD, Jamie M Guidry Auvil, Malcolm A. Smith, MD PhD, Tanja M. Davidsen, PhD, Leandro C. Hermida, Patee Gesuwan, Marco A. Marra, PhD, Yussanne Ma, PhD, Andrew J. Mungall, Richard Moore, PhD, Daniela S. Gerhard, PhD, Xueyuan Cao, Lei Shi, PhD, Stanley Pounds, PhD, Hiroto Inaba, MD PhD, Charles Mullighan, MBBS, MSc, MD

Blood (2016) 128 (22): 454.

https://doi.org/10.1182/blood.V128.22.454.454

Published: 2016

Journal Articles

Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol

Blood (2015) 126 (23): 1414.

https://doi.org/10.1182/blood.V126.23.1414.1414

Published: 2015

Journal Articles

Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients

Blood (2015) 126 (23): 252.

https://doi.org/10.1182/blood.V126.23.252.252

Published: 2015

Journal Articles

New Targets in Cytometric Investigation of Acute Leukemia Selected From Gene Profiling Studies

Martina Vaskova, PhD, Ester Mejstrikova, MD, PhD, Tomas Brdicka, PhD, Pavla Angelisova, PhD, Tomas Kalina, MD, PhD, Veronika Kanderova, MSc, Daniela Cerna, MSc, Martin Kovac, MSc, Jan Trka, MD, PhD, Fridtjof Lund-Johansen, MD, PhD, Jan Stary, M.D., Ondrej Hrusak, MD., PhD.

Blood (2011) 118 (21): 2536.

https://doi.org/10.1182/blood.V118.21.2536.2536

Published: 2011

Journal Articles

Changes Identified by Flow Cytometry and WT1 Expression in Consecutive Bone Marrow Samples in Refractory Cytopenia of Childhood and Aplastic Anemia Before Start of the Therapy

Michaela Reiterova, MD, Karolina Kramarzova, Martina Sukova, MD, Vit Campr, MD, Elena Vodickova, MD, Ondrej Zapletal, MD, Jan Blatny, MD, PhD, Zuzana Zemanova, Libuse Lizcova, Vendula Pelkova, Jan Trka, MD, PhD, Jan Stary, M.D., Ondrej Hrusak, MD., PhD., Ester Mejstrikova, MD, PhD

Blood (2011) 118 (21): 1342.

https://doi.org/10.1182/blood.V118.21.1342.1342

Published: 2011

Journal Articles

Dual Production of IL-2 and IFN-Gamma by CMV-Specific CD8+ T-Cells Is a Hallmark of Their Ability to Control CMV Reactivation in Patients After Hematopoietic Stem Cell Transplantation,

Tomas Kalina, MD, PhD, Ladislav Krol, MD., Jan Stuchly, MSc., Petra Keslova, MD., Petr Hubacek, MD., Ondrej Pelak, Petr Sedlacek, MD, PhD, Jan Stary, M.D., Ondrej Hrusak, MD., PhD.

Blood (2011) 118 (21): 4081.

https://doi.org/10.1182/blood.V118.21.4081.4081

Published: 2011

Journal Articles

Results of the Randomized I-BFM-SG Trial „Acute Lymphoblastic Leukemia Intercontinental-BFM 2002“ in 5060 Children Diagnosed in 15 Countries on 3 Continents

Blood (2011) 118 (21): 872.

https://doi.org/10.1182/blood.V118.21.872.872

Published: 2011

Journal Articles

Acute Bilineal Leukemia Is a Very Rare Entity in Childhood

Ester Mejstrikova, MD, PhD, Lucie Slamova, Eva Fronkova, Jana Volejnikova, MD, Katerina Muzikova, Jiri Domansky, Jaroslav Sterba, Ondrej Zapletal, MD, Zuzana Zemanova, Libuse Lizcova, Elena Vodickova, MD, Jan Zuna, Jan Trka, MD, PhD, Jan Stary, M.D., Ondrej Hrusak, MD., PhD.

Blood (2011) 118 (21): 4871.

https://doi.org/10.1182/blood.V118.21.4871.4871

Published: 2011

Journal Articles

B Precursor ALL Subset with Aberrant CD2 Expression and a Specific Predisposition to Early Monocytic Transdifferentiation

Ester Mejstrikova, MD, PhD, Lucie Slamova, MD, Eva Fronkova, MD, PhD, Jan Zuna, MD, PhD, Jean-Pierre Bourquin, MD, PhD, Elena Vodickova, MD, Katerina Muzikova, Zuzana Zemanova, PhD, Vendula Pelkova, Frederik Van Delft, PhD, Tomas Kalina, MD, PhD, Karel Fiser, PhD, Petr Smisek, MD, Jan Trka, MD, PhD, Jan Stary, MD, DrSc, Ondrej Hrusak, MD, PhD

Blood (2010) 116 (21): 1708.

https://doi.org/10.1182/blood.V116.21.1708.1708

Published: 2010

Journal Articles

Diagnostic Value and Limitations of FDG-PET for the Staging of Childhood Lymphomas.

Edita Kabickova, MD, Jana Votrubova, MD, PhD, David Sumerauer, MD, PhD, Ester Mejstrikova, MD, PhD, Ondrej Hrusak, MD, PhD, Martin Kyncl, MD, Roman Kodet, MD, Prof., Jan Stary, MD, PhD, Otakar Belohlavek, MD, PhD

Blood (2009) 114 (22): 3658.

https://doi.org/10.1182/blood.V114.22.3658.3658

Published: 2009

Journal Articles

CD44 and CD27 Expression Delineates Stages of B Precursor Development Reflecting Recombination Status and Propensity to Leukemic Transformation.

Martina Vaskova, Eva Fronkova, MD,PhD, Julia Starkova, Tomas Kalina, MD,PhD, Ester Mejstrikova, MD, Ondrej Hrusak, MD,PhD

Blood (2006) 108 (11): 1671.

https://doi.org/10.1182/blood.V108.11.1671.1671

Published: 2006

Journal Articles

Standardized 4 Color Flow Cytometric Minimal Residual Disease Detection Failed To Overcome Regeneration Problems but Identifies Early Blast Clearence Predictive of Molecular Remission after Induction in Childhood B Lineage Leukemia.

Ester Mejstrikova, MD, Eva Fronkova, MD, PhD, Drago Batinic, MD, PhD, Klara Dubravcic, Flora Kiss, MD, Janos Kappelmayer, MD, PhD, Drorit Luria, PhD, Alice Suk Hang Cheng, BSc, PhD, Batia Stark, MD, PhD, Margaret Ng, MD, PhD, Yonna Leung, Bsc, Shai Izraeli, MD, PhD, Martina Vaskova, MSc, Katerina Zdrahalova, MD, Jan Trka, MD, PhD, Jan Stary, MD, PhD, Tomas Kalina, MD, PhD, Ondrej Hrusak, MD, PhD

Blood (2006) 108 (11): 1842.

https://doi.org/10.1182/blood.V108.11.1842.1842

Published: 2006

Journal Articles

Minitransplant Using Repeated Unrelated Donor Lymphocyte Infusions as a Treatment of Immunodeficiency in Complete DiGeorge Syndrome.

Renata Formankova, MD, Katerina Zdrahalova, MD, Petr Sedlacek, MD, PhD, Petra Keslova, MD, Ondrej Hrusak, MD, PhD, Ester Mejstrikova, MD, Tomas Kalina, MD, Hana Zizkova, MD, Anna Sediva, MD, PhD, Jirina Bartunkova, MD, PhD, Karel Dlask, MD, Jan Stary, MD, PhD

Blood (2005) 106 (11): 5438.

https://doi.org/10.1182/blood.V106.11.5438.5438

Published: 2005

Journal Articles

Minimal Residual Disease Monitoring by Four Color Flow Cytometry before Second Induction Is an Independent Prognostic Factor in Childhood Acute Myeloid Leukemia - AML-BFM MRD Study Group.

Claudia Langebrake, PhD, Michael Dworzak, MD, Ondrej Hrusak, MD, Ester Mejstrikova, MD, Frank Griesinger, MD, Martin Zimmermann, PhD, Ursula Creutzig, MD, Dirk Reinhardt, MD

Blood (2005) 106 (11): 671.

https://doi.org/10.1182/blood.V106.11.671.671

Published: 2005

Journal Articles

CD33 - but Not Myeloid Antigens in General - Heralds Poor Prognosis in Childhood B Precursor ALL. Czech Pediatric Hematology Working Group (CPH) Population-Based Study.

Ester Mejstrikova, MD, Martina Vaskova, MSc, Tomas Kalina, MD, Jan Trka, MD, PhD, Jan Stary, MD, DSc, Ondrej Hrusak, MD, PhD

Blood (2004) 104 (11): 1078.

https://doi.org/10.1182/blood.V104.11.1078.1078

Published: 2004

Journal Articles

Minimal Residual Disease Detection Identifies Differences between the Risk Groups Defined by the ALL IC-BFM 2002 and the ALL-BFM 2000 Protocols.

Eva Fronkova, MD, Leona Reznickova, Katerina Muzikova, Ester Mejstrikova, MD, Ondrej Hrusak, MD, PhD, Martin Schrappe, MD, PhD, Jan Stary, MD, PhD, Jan Trka, MD, PhD

Blood (2004) 104 (11): 1085.

https://doi.org/10.1182/blood.V104.11.1085.1085

Published: 2004

NARROW

In Vitro Drug Response Profiling in BCP- and T-ALL Primary Samples Adds a Robust Functional Layer Enabling Optimized Guidance of Individualized Therapy in Relapsed and Refractory Pediatric Acute Leukemia Patients

Transient Switch to Myeloid Lineage in Acute Lymphoblastic Leukemia during Induction Therapy: The Role of CD371 Expression and Implication for Minimal Residual Disease Detection

Deep Immunoprofiling By Flow Cytometry and NGS Reveals Distinct T Cell Profile in Pediatric Hepatitis-Associated Aplastic Anemia

Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies

Genomic Landscape of Pediatric Mixed Phenotype Acute Leukemia

Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol

Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients

New Targets in Cytometric Investigation of Acute Leukemia Selected From Gene Profiling Studies

Changes Identified by Flow Cytometry and WT1 Expression in Consecutive Bone Marrow Samples in Refractory Cytopenia of Childhood and Aplastic Anemia Before Start of the Therapy

Dual Production of IL-2 and IFN-Gamma by CMV-Specific CD8+ T-Cells Is a Hallmark of Their Ability to Control CMV Reactivation in Patients After Hematopoietic Stem Cell Transplantation,

Results of the Randomized I-BFM-SG Trial „Acute Lymphoblastic Leukemia Intercontinental-BFM 2002“ in 5060 Children Diagnosed in 15 Countries on 3 Continents

Acute Bilineal Leukemia Is a Very Rare Entity in Childhood

B Precursor ALL Subset with Aberrant CD2 Expression and a Specific Predisposition to Early Monocytic Transdifferentiation

Diagnostic Value and Limitations of FDG-PET for the Staging of Childhood Lymphomas.

CD44 and CD27 Expression Delineates Stages of B Precursor Development Reflecting Recombination Status and Propensity to Leukemic Transformation.

Standardized 4 Color Flow Cytometric Minimal Residual Disease Detection Failed To Overcome Regeneration Problems but Identifies Early Blast Clearence Predictive of Molecular Remission after Induction in Childhood B Lineage Leukemia.

Minitransplant Using Repeated Unrelated Donor Lymphocyte Infusions as a Treatment of Immunodeficiency in Complete DiGeorge Syndrome.

Minimal Residual Disease Monitoring by Four Color Flow Cytometry before Second Induction Is an Independent Prognostic Factor in Childhood Acute Myeloid Leukemia - AML-BFM MRD Study Group.

CD33 - but Not Myeloid Antigens in General - Heralds Poor Prognosis in Childhood B Precursor ALL. Czech Pediatric Hematology Working Group (CPH) Population-Based Study.

Minimal Residual Disease Detection Identifies Differences between the Risk Groups Defined by the ALL IC-BFM 2002 and the ALL-BFM 2000 Protocols.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only